 Home > Biochemical Engineering > Polypeptide > Tirzepatide for Sale > Tirzepatide cas2023788-19-2 Losing weight can improve metabolic and cardiovascular health.

Tirzepatide cas2023788-19-2 Losing weight can improve metabolic and cardiovascular health. buy - large image1

Tirzepatide cas2023788-19-2 Losing weight can improve metabolic and cardiovascular health. buy - image1

Tirzepatide cas2023788-19-2 Losing weight can improve metabolic and cardiovascular health. buy - image2

Tirzepatide cas2023788-19-2 Losing weight can improve metabolic and cardiovascular health. buy - image3

Tirzepatide cas2023788-19-2 Losing weight can improve metabolic and cardiovascular health. buy - image4

Tirzepatide cas2023788-19-2 Losing weight can improve metabolic and cardiovascular health.

Name: Tirzepatide cas2023788-19-2 Losing weight can improve metabolic and cardiovascular health.
Brand: comings
SKU: pr2403011036
Price: 12.03 USD
Availability: InStock

TDS 2115 Inquiries

Unit Price: Get Latest Price 

CAS No.:

2023788-19-2

Port:

shanghai

Brand:

comings

Packaging:

1g 10g 100g 1000g

Price valid (until):

2025-05-14

Contact Supplier

 Chat Now

Wuhan Comings Biotechnology Co., Ltd.

Company Type:

Trader

Location:

China

Payment Terms:

TT against copy of documents,100% TT in advance

Average Lead Time:

15 days

Qualification:

Main Products:

semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Product Detail

Items

Specifications

Storage conditions

2-8°C

Tilpotide uses

Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide[1].

Tilpotide uses

Taking the drug not only promotes additional weight loss but also improves metabolic and cardiovascular health.

ECHEMI Editorial Reference

Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

Certificates

Basic Info

Product Name:

Tirzepatide

Other Name:

LY3298176;

CAS No.:

2023788-19-2

Molecular Formula:

C225H348N48O68

Molecular Weight:

4813

EC Number:

200-001-8

Categories:

Polypeptide

Characteristics

Appearance:

White to off-white

Research

Class:

Dual agonist — GIPR, GLP-1R

Status:

FDA-approved (Mounjaro / Zepbound)

Mechanism:

Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

EC50 (Human GLP1R):

0.934 nM

EC50 (Human GIPR):

0.0224 nM

Source:

Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

Clinical Development:

NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503

FDA:

Mounjaro, Zepbound (approved 2022-05-13)

References

ChEMBL:

DrugBank:

KEGG DRUG:

PubChem:

Literature:

NEJM: Frias et al. (2021) — SURPASS-2; FDA: Mounjaro (NDA 215866)

Disclaimer:

Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

See More Tirzepatide Properties 

Seller Information

Business Type:
Trader

Main Products:
semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332

Location:
No. 1, 19th Floor, Unit 2, Building 5, Southeast Residential Building (Hankou Yujiang Lanting), at the intersection of Hanshi Highway and Fufa South Road, Wuhu Street, Huangpi District, Wuhan City, Hu

Payment Terms:
TT against copy of documents,100% TT in advance

Average lead Time:
15 days

Total Annual Revenue:
$1 million-$2.5 million

Total Employees:
11-50

Year of Establishment:
2023

We prospectively allocates international cutting-edge production and testing equipment and environmental protection facilities. The 5 production lines can achieve an annual output of 1000Kg. We to be the best chemical manufacture in China,and will become a trustworthy supplier of chemicals for global customers.
Our main products include peptides, cognitive enhancers, pharmaceutical intermediates, and botanical extracts.
And our main clients cover: pharmaceutical companies, hospitals, laboratories in higher education institutions, and cosmetic companies.
Since its establishment, our company's products have been exported to regions including Europe, the Americas, the Middle East and so on. Our commitment to high product quality and excellent after-sales service has provided customers with a positive experience.
Wuhan Comings Biotechnology Co., Ltd. is looking forward to cooperating with you with professional knowledge, high-quality service and competitive price!

Inquiry History

2115 Inquiries

Country	Product	Purchase Quantity	Date Posted
United States	2023788-19-2 in unlabeled vials 10, 15 and 30 mg	10	Feb 14, 2024
United States	Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries	10 MG	Apr 3, 2024
United States	Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides	2 MT	Dec 13, 2025
Brazil	2023788-19-2	20 PCS	Sep 12, 2026
Germany	2023788-19-2	1 MG	Jun 18, 2026
United States	2023788-19-2 Trizepatide	10 MT	Oct 29, 2023
United States	Tirzepatide 2023788-19-2	2	Feb 19, 2024
United States	Tirzepatide 2023788-19-2	10 G	Oct 31, 2023
United States	Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder	1	Dec 2, 2025
United States	Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2	1 MT	Jan 25, 2024
United States	Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide	1 MT	Oct 20, 2023
United States	supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder	10 MG	Apr 4, 2024
United States	Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss	2 KG	Oct 20, 2023
Kenya	Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2	30 MG	Dec 26, 2025
United States	Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide	10	Dec 30, 2024
United Kingdom	Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire	100 G	Nov 4, 2023
Canada	99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2	2 MT	Oct 22, 2023
Bolivia	peptideos	10000 G	Feb 12, 2026
United Kingdom	tirzepatide	10 MG	Oct 21, 2025
Malaysia	Tirzepatide	40 MG	Jul 23, 2026

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
Tirzepatide Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa	Pharmaceutical Grade/99	$1/G FOB	Yingtai Technology Co., Ltd	Inquiry
Tirzepatide ML	Pharmaceutical Grade/99.4	$1/G FOB	MELOS BIOTECH (SHENZHEN) CO., LIMITED	Inquiry
High-quality and cost-effective Tirzepatide (CAS:2023788-19-2) powder,a weight-loss peptide, supports customization with a purity of up to	Pharmaceutical Grade/99	$50/UNIT FOB	FengMing Peptide Trading	Inquiry
TR60 Research Peptide Powder 60mg For Laboratory Research Use	Research Grade/99	$106-136/UNIT FOB	TONGQI FUTYRE LIMITED	Inquiry
AOD \| China Factory Supply \| Cosmetic Peptide \| 99% Purity \| 2mg*10Vials \| Lyophilized Powder	Pharmaceutical Grade/99	$51/UNIT FOB	Hangzhou Zhongqing Trading Co., Ltd	Inquiry

Tirzepatide cas2023788-19-2 Losing weight can improve metabolic and cardiovascular health.

Product Description

Seller Information

Inquiry History

More Choices Find All Products for Sale 

Related Searches

More from this Seller